{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:08:40Z","timestamp":1790816920634,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T00:00:00Z","timestamp":1352332800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s10741-012-9354-7","type":"journal-article","created":{"date-parts":[[2012,11,7]],"date-time":"2012-11-07T07:52:36Z","timestamp":1352274756000},"page":"237-246","source":"Crossref","is-referenced-by-count":28,"title":["Efficacy and safety of loop diuretic therapy in acute decompensated heart failure: a clinical review"],"prefix":"10.1007","volume":"19","author":[{"given":"Laura","family":"Leto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Aspromonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Feola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,8]]},"reference":[{"issue":"Suppl","key":"9354_CR1","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1016\/S0002-8703(98)70251-0","volume":"135","author":"KF Adams","year":"1998","unstructured":"Adams KF, Zannad F (1998) Clinical definition and epidemiology of advanced heart failure. Am Heart J 135(Suppl):S204\u2013S215","journal-title":"Am Heart J"},{"key":"9354_CR2","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1067\/mhj.2003.150","volume":"145","author":"GM Felker","year":"2003","unstructured":"Felker GM, Adams KF, Konstam MA, O\u2019Connor CM, Gheorghiade M (2003) The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J 145:S18\u2013S25","journal-title":"Am Heart J"},{"key":"9354_CR3","unstructured":"Members of the Statistics C, Stroke Statistics S, Thom T, Haase N, Rosamond W et al (2006) Heart disease and stroke statistics\u20142006 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 113:e85\u2013151.151"},{"key":"9354_CR4","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.cardfail.2004.06.367","volume":"10","author":"CL Emerman","year":"2004","unstructured":"Emerman CL, Marco TD, Costanzo MR, Peacock WF, for the ASAC (2004) Impact of intravenous diuretics on the outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE(R) registry. J Card Fail 10:S116\u2013S117","journal-title":"J Card Fail"},{"key":"9354_CR5","doi-asserted-by":"crossref","unstructured":"Jessup M, Abraham WT, Casey et al (2009) Focused update: ACCF\/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53:1343\u20131382","DOI":"10.1016\/j.jacc.2008.11.009"},{"key":"9354_CR6","doi-asserted-by":"crossref","unstructured":"Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29(19):2388\u20132442","DOI":"10.1093\/eurheartj\/ehn309"},{"issue":"1","key":"9354_CR7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-3565(25)38809-9","volume":"236","author":"JF Valentine","year":"1986","unstructured":"Valentine JF, Brater DC, Krejs GJ (1986) Clearance of furosemide by the gastrointestinal tract. J Pharmacol Exp Ther 236(1):177\u2013180","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"9354_CR8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/clpt.1980.148","volume":"28","author":"DC Brater","year":"1980","unstructured":"Brater DC, Chennavasin P, Seiwell R (1980) Furosemide in patients with heart failure: shift in dose\u2013response curves. Clin Pharmacol Ther 28(2):182\u2013186","journal-title":"Clin Pharmacol Ther"},{"key":"9354_CR9","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/hc1102.105264","volume":"105","author":"SS Gottlieb","year":"2002","unstructured":"Gottlieb SS, Brater DC, Thomas I et al (2002) BG9719 (CVT-124), An A(1) adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 105:1348\u20131353","journal-title":"Circulation"},{"issue":"3","key":"9354_CR10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7326\/0003-4819-102-3-314","volume":"102","author":"MR Vasko","year":"1985","unstructured":"Vasko MR, Cartwright DB, Knochel JP, Nixon JV, Brater DC (1985) Furosemide absorption altered in decompensated congestive heart failure. Ann Intern Med 102(3):314\u2013318","journal-title":"Ann Intern Med"},{"key":"9354_CR11","doi-asserted-by":"crossref","unstructured":"Felker GM (2011) Loop diuretics in heart failure. Heart Fail Rev, 2011 April 23. Epub ahead of print","DOI":"10.1007\/s10741-011-9245-3"},{"key":"9354_CR12","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/eurheartj\/ehi859","volume":"27","author":"MR Cowie","year":"2006","unstructured":"Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B (2006) POSH Investigators. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 27:1216\u20131222","journal-title":"Eur Heart J"},{"issue":"10","key":"9354_CR13","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ejheart.2007.07.011","volume":"9","author":"V Hasselblad","year":"2007","unstructured":"Hasselblad V, Stough WG, Shah MR, Lokhnygina Y, O\u2019Connor CM, Califf RM, Adams Jr KF (2007) Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE Trial. Eur J Heart Fail 9(10):1064\u20131069","journal-title":"Eur J Heart Fail"},{"key":"9354_CR14","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/eurjhf\/hfr121","volume":"13","author":"MB Yilmaz","year":"2011","unstructured":"Yilmaz MB, Gayat E, Mebazaa A et al (2011) Impact of diuretic dosing on mortality in acute heart failure using a propensity-matching analysis. Eur J Heart Fail 13:1244\u20131252","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"9354_CR15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2003.08.012","volume":"147","author":"J Butler","year":"2004","unstructured":"Butler J, Forman DE, Abraham WT et al (2004) Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 147(2):331\u2013338","journal-title":"Am Heart J"},{"key":"9354_CR16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.109.933275","volume":"122","author":"JM Testani","year":"2010","unstructured":"Testani JM, Jennifer Chen BS et al (2010) Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122:265\u2013272","journal-title":"Circulation"},{"key":"9354_CR17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cardfail.2010.02.001","volume":"16","author":"D Aronson","year":"2010","unstructured":"Aronson D, Burger AJ (2010) The relationship between transitory and persistent worsening renal function and mortality in patients with acute decompensated heart failure. J Card Fail 16:541\u2013547","journal-title":"J Card Fail"},{"key":"9354_CR18","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.CIR.100.12.1311","volume":"100","author":"HA Cooper","year":"1999","unstructured":"Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ (1999) Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 100:1311\u20131315","journal-title":"Circulation"},{"key":"9354_CR19","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/eurheartj\/ehi890","volume":"27","author":"A Ahmed","year":"2006","unstructured":"Ahmed A, Husain A, Love TE et al (2006) Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 27:1431\u20131439","journal-title":"Eur Heart J"},{"issue":"4","key":"9354_CR20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cardfail.2010.11.003","volume":"17","author":"G Parrinello","year":"2011","unstructured":"Parrinello G, Paterna S, Di Pasquale P et al (2011) Changes in estimating echocardiography pulmonary capillary wedge pressure after hypersaline plus furosemide versus furosemide alone in decompensated heart failure. J Card Fail 17(4):331\u2013339","journal-title":"J Card Fail"},{"key":"9354_CR21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1159\/000082314","volume":"24","author":"GH Kim","year":"2004","unstructured":"Kim GH (2004) Long-term adaptation of renal ion transporters to chronic diuretic treatment. Am J Nephrol 24:595\u2013605","journal-title":"Am J Nephrol"},{"key":"9354_CR22","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7326\/0003-4819-114-10-886","volume":"114","author":"DH Ellison","year":"1991","unstructured":"Ellison DH (1991) The physiologic basis of diuretic synergism: its role in treating diuretic resistance. Ann Intern Med 114:886\u2013894","journal-title":"Ann Intern Med"},{"key":"9354_CR23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ki.1989.246","volume":"36","author":"NR Loon","year":"1989","unstructured":"Loon NR, Wilcox CS, Unwin RJ (1989) Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 36:682\u2013689","journal-title":"Kidney Int"},{"issue":"3","key":"9354_CR24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MAJ.0b013e3181591da0","volume":"335","author":"Y Selektor","year":"2008","unstructured":"Selektor Y, Weber KT (2008) The salt-avid state of congestive heart failure revisited. Am J Med Sci 335(3):209\u2013218","journal-title":"Am J Med Sci"},{"key":"9354_CR25","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/jama.298.17.2009","volume":"298","author":"JJ McMurray","year":"2007","unstructured":"McMurray JJ, Teerlink JR, Cotter G et al (2007) Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. JAMA 298:2009\u20132019","journal-title":"JAMA"},{"key":"9354_CR26","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","volume":"297","author":"M Gheorghiade","year":"2007","unstructured":"Gheorghiade M, Konstam MA, Burnett JC Jr, for the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan I et al (2007) Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST clinical status trials. JAMA 297:1332\u20131343","journal-title":"JAMA"},{"key":"9354_CR27","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0002-9610(83)90344-6","volume":"146","author":"JG Copeland","year":"1983","unstructured":"Copeland JG, Campbell DW, Plachetka JR, Salmon NW, Larson DF (1983) Diuresis with continuous infusion of furosemide after cardiac surgery. Am J Surg 146:796","journal-title":"Am J Surg"},{"issue":"3","key":"9354_CR28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0003-4975(90)90505-Z","volume":"50","author":"JA Magovern","year":"1990","unstructured":"Magovern JA, Magovern GJ Jr (1990) Diuresis in hemodynamically compromised patients: continuous furosemide infusion. Ann Thorac Surg 50(3):482\u2013484","journal-title":"Ann Thorac Surg"},{"key":"9354_CR29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-115-5-360","volume":"115","author":"DW Rudy","year":"1991","unstructured":"Rudy DW, Voelker JR, Greene PK et al (1991) Loop diuretics for chronic renal insufficiency: continuous infusion is more efficacious than bolus therapy. Ann Intern Med 115:360\u2013366","journal-title":"Ann Intern Med"},{"key":"9354_CR30","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/bmj.2.6135.476","volume":"2","author":"DH Lawson","year":"1978","unstructured":"Lawson DH, Gray JMB, Henry DA, Tilstone WJ (1978) Continuous infusion of furosemide in refractory edema. BMJ 2:476","journal-title":"BMJ"},{"issue":"4","key":"9354_CR31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2796.1994.tb01082.x","volume":"235","author":"JJ Meyel van","year":"1994","unstructured":"van Meyel JJ, Smits P, Dormans T, Gerlag PG, Russel FG, Gribnau FW (1994) Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance. J Intern Med 235(4):329\u2013334","journal-title":"J Intern Med"},{"key":"9354_CR32","doi-asserted-by":"crossref","unstructured":"Salvator DR, Rey NR, Ramos GC, Punzalan FE (2005) Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 3: CD003178","DOI":"10.1002\/14651858.CD003178.pub3"},{"key":"9354_CR33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0735-1097(96)00161-1","volume":"28","author":"TPJ Dormans","year":"1996","unstructured":"Dormans TPJ, van Meyel JJM, Gerlag PGG et al (1996) Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol 28:376\u2013382","journal-title":"J Am Coll Cardiol"},{"key":"9354_CR34","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1378\/chest.102.3.725","volume":"102","author":"M Lahav","year":"1992","unstructured":"Lahav M, Regev A, Ra\u2019anani P, Theodor E (1992) Intermittent administration of furosemide vs. continuous infusion preceded by a loading dose for congestive heart failure. Chest 102:725\u2013731","journal-title":"Chest"},{"key":"9354_CR35","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1067\/mhj.2003.166","volume":"145","author":"G Licata","year":"2003","unstructured":"Licata G, Di Pasquale P, Parrinello G et al (2003) Effects of high-doses furosemide and small volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J 145:459\u2013466","journal-title":"Am Heart J"},{"key":"9354_CR36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/00365519709099409","volume":"57","author":"E Aaser","year":"1997","unstructured":"Aaser E, Gullestad L, Tollofsrud S et al (1997) Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure. Scand J Clin Lab Investig 57:361\u2013368","journal-title":"Scand J Clin Lab Investig"},{"key":"9354_CR37","first-page":"279","volume":"31","author":"J Bagatin","year":"1993","unstructured":"Bagatin J, Sardelic S, Gancevic I et al (1993) Diuretic efficiency of furosemide in continuous intravenous infusion vs. bolus injection in congestive heart failure: results of a pilot study. Pharmaca 31:279\u2013286","journal-title":"Pharmaca"},{"key":"9354_CR38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/j.1552-4604.1996.tb04197.x","volume":"36","author":"WG Kramer","year":"1996","unstructured":"Kramer WG, Smith WB, Ferguson J et al (1996) Pharmacodynamics of torsemide administered as intravenous injection and as a continuous infusion to patients with congestive heart failure. J Clin Pharmacol 36:265\u2013270","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"9354_CR39","first-page":"121","volume":"18","author":"N Pivac","year":"1998","unstructured":"Pivac N, Rumboldt Z, Sardelic S et al (1998) Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. Int J Clin Pharmacol Res 18(3):121\u2013128","journal-title":"Int J Clin Pharmacol Res"},{"key":"9354_CR40","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1097\/00003246-199712000-00011","volume":"25","author":"D Schuller","year":"1997","unstructured":"Schuller D, Lynch J, Fine D (1997) Protocol-guided diuretic management: comparison of furosemide by continuous infusion and intermittent bolus. Crit Care Med 25:1969\u20131975","journal-title":"Crit Care Med"},{"key":"9354_CR41","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.amjcard.2010.01.355","volume":"105","author":"LA Allen","year":"2010","unstructured":"Allen LA, Turer AT, Dewald T, Stough WG, Cotter G, O\u2019Connor CM (2010) Continuous versus bolus dosing of furosemide for patients hospitalized for heart failure. Am J Cardiol 105:1794\u20131797","journal-title":"Am J Cardiol"},{"key":"9354_CR42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cardfail.2009.11.005","volume":"16","author":"MR Thomson","year":"2010","unstructured":"Thomson MR, Nappi JM, Dunn SP, Hollis IB, Rodgers JE, Van Bakel AB (2010) Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. J Card Fail 16:188\u2013193","journal-title":"J Card Fail"},{"issue":"3","key":"9354_CR43","first-page":"227","volume":"52","author":"EF Aziz","year":"2011","unstructured":"Aziz EF, Alviar CL, Herzog E et al (2011) Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days. Hell J Cardiol 52(3):227\u2013235","journal-title":"Hell J Cardiol"},{"issue":"9","key":"9354_CR44","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"GM Felker","year":"2011","unstructured":"Felker GM, Lee KL, Bull DA et al (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364(9):797\u2013805","journal-title":"N Engl J Med"},{"key":"9354_CR45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jhm.991","volume":"7","author":"M Amer","year":"2012","unstructured":"Amer M, Adomaityte J, Qayyum R (2012) Continuous infusion versus intermittent bolus furosemide in ADHF: an update meta-analysis of randomized control trials. J Hosp Med 7:270\u2013275","journal-title":"J Hosp Med"},{"key":"9354_CR46","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","volume":"297","author":"MA Konstam","year":"2007","unstructured":"Konstam MA, Gheorghiade M, Burnett JC Jr, for the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan I et al (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trials. JAMA 297:1319\u20131331","journal-title":"JAMA"},{"issue":"8","key":"9354_CR47","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.cardfail.2008.06.003","volume":"14","author":"SR Goldsmith","year":"2008","unstructured":"Goldsmith SR, Elkayam U, Haught WH et al (2008) Efficacy and safety of the vasopressin V1A\/V2-receptor antagonist conivaptan in acute decompensated heat failure: a dose-ranging pilot study. J Card Fail 14(8):641\u2013647","journal-title":"J Card Fail"},{"issue":"8","key":"9354_CR48","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cardfail.2008.08.010","volume":"14","author":"G Cotter","year":"2008","unstructured":"Cotter G, Dittrich HC, Weatherley BD, Protect Steering Committee, Investigators and Coordinators et al (2008) The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. J Card Fail 14(8):631\u2013640","journal-title":"J Card Fail"},{"issue":"19","key":"9354_CR49","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.jacc.2010.11.057","volume":"57","author":"AA Voors","year":"2011","unstructured":"Voors AA, Dittrich HC, Massie BM et al (2011) Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (placebo-controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function). JACC 57(19):1899\u20131907","journal-title":"JACC"},{"key":"9354_CR50","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","volume":"49","author":"MR Costanzo","year":"2007","unstructured":"Costanzo MR, Guglin ME, Saltzberg MT et al (2007) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. JACC 49:675\u2013683","journal-title":"JACC"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-012-9354-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-012-9354-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-012-9354-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T10:30:45Z","timestamp":1745145045000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-012-9354-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,8]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["9354"],"URL":"https:\/\/doi.org\/10.1007\/s10741-012-9354-7","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,8]]}}}